Harvard Bioscience (HBIO) EBT Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 30.64% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -58.07% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 20.18% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.48% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -39.89% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.41% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -34.42% |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -67.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -67.98% |
| Dec 31, 2025 | -53.15% |
| Sep 30, 2025 | 37.70% |
| Jun 30, 2025 | -38.54% |
| Mar 31, 2025 | -93.43% |
| Dec 31, 2024 | -19.50% |
| Sep 30, 2024 | -366.93% |
| Jun 30, 2024 | -73.14% |
| Mar 31, 2024 | -87.16% |
| Dec 31, 2023 | -26.26% |
| Sep 30, 2023 | 26.49% |
| Jun 30, 2023 | -34.20% |
| Mar 31, 2023 | 31.44% |
| Dec 31, 2022 | -123.08% |
| Sep 30, 2022 | -20.60% |
| Jun 30, 2022 | 71.25% |
| Mar 31, 2022 | -57.57% |
| Dec 31, 2021 | 192.92% |
| Sep 30, 2021 | 27.02% |
| Jun 30, 2021 | 30.31% |